These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9264999)

  • 61. Sepsis and septic shock.
    Maloney PJ
    Emerg Med Clin North Am; 2013 Aug; 31(3):583-600. PubMed ID: 23915595
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The design and implementation of trials of host modulation agents.
    Offenbacher S; Salvi GE; Beck JD; Williams RC
    Ann Periodontol; 1997 Mar; 2(1):199-212. PubMed ID: 9151554
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The current understanding of sepsis and research priorities for the future.
    Opal SM
    Virulence; 2014 Jan; 5(1):1-3. PubMed ID: 24153016
    [No Abstract]   [Full Text] [Related]  

  • 64. The new trials of early goal-directed resuscitation: three-part harmony or disharmony?
    Russell JA; Vincent JL
    Intensive Care Med; 2013 Oct; 39(10):1867-9. PubMed ID: 23958740
    [No Abstract]   [Full Text] [Related]  

  • 65. Immunotherapy of sepsis syndrome: a comparison of the available treatments.
    Fisher CJ; Bellingan G
    Klin Wochenschr; 1991; 69 Suppl 26():162-7. PubMed ID: 1813714
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cytokine modifiers: pipe dream or reality?
    Abraham E
    Chest; 1998 Mar; 113(3 Suppl):224S-227S. PubMed ID: 9515897
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Evaluation models for therapy planning/standardization exemplified by infection].
    Encke A; Hanisch E; Sitter H; Greger B; Bauhofer A; Margolis C; Lorenz W
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():323-9. PubMed ID: 9574147
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment of septic shock with immunotherapy.
    Smith AL
    Pharmacotherapy; 1998; 18(3):565-80. PubMed ID: 9620107
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunologic therapy for ARDS, septic shock, and multiple-organ failure.
    St John RC; Dorinsky PM
    Chest; 1993 Mar; 103(3):932-43. PubMed ID: 8449096
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Progress in therapy of infection].
    Müller-Werdan U; Buerke M; Werdan K
    Internist (Berl); 2003 Dec; 44(12):1531-40. PubMed ID: 14689196
    [No Abstract]   [Full Text] [Related]  

  • 71. Surgical infections: blocking the mediator cascade responsible for sepsis and septic shock.
    Fink MP
    Curr Opin Gen Surg; 1993; ():19-25. PubMed ID: 7583965
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Goal-directed therapy in small animal critical illness.
    Butler AL
    Vet Clin North Am Small Anim Pract; 2011 Jul; 41(4):817-38, vii. PubMed ID: 21757095
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The costs of septic syndromes in the intensive care unit and influence of hospital-acquired sepsis.
    Brun-Buisson C; Roudot-Thoraval F; Girou E; Grenier-Sennelier C; Durand-Zaleski I
    Intensive Care Med; 2003 Sep; 29(9):1464-71. PubMed ID: 12856120
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Blood and plasma treatments: high-volume hemofiltration--a global view.
    Honoré PM; Joannes-Boyau O; Gressens B
    Contrib Nephrol; 2007; 156():371-86. PubMed ID: 17464148
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Postoperative sepsis: diagnosis, special features, management].
    Utzolino S; Hopt UT; Kaffarnik M
    Zentralbl Chir; 2010 Jun; 135(3):240-8. PubMed ID: 20549587
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Extracorporeal therapies in non-renal disease: treatment of sepsis and the peak concentration hypothesis.
    Ronco C; Bonello M; Bordoni V; Ricci Z; D'Intini V; Bellomo R; Levin NW
    Blood Purif; 2004; 22(1):164-74. PubMed ID: 14732825
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock.
    Clec'h C; Fosse JP; Karoubi P; Vincent F; Chouahi I; Hamza L; Cupa M; Cohen Y
    Crit Care Med; 2006 Jan; 34(1):102-7. PubMed ID: 16374163
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Do monoclonal antibodies and anticytokines still have a future in infectious diseases?
    Cohen J; Heumann D; Glauser MP
    Am J Med; 1995 Dec; 99(6A):45S-52S; discussion 52S-53S. PubMed ID: 8585536
    [TBL] [Abstract][Full Text] [Related]  

  • 79. IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.
    Hentrich M; Fehnle K; Ostermann H; Kienast J; Cornely O; Salat C; Ubelacker R; Buchheidt D; Behre G; Hiddemann W; Schiel X
    Crit Care Med; 2006 May; 34(5):1319-25. PubMed ID: 16540956
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Toxic shock syndrome].
    Thurnheer U; Kuske A
    Schweiz Rundsch Med Prax; 1985 Aug; 74(33):862-5. PubMed ID: 4048715
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.